Independent · evidence-based · non-judgmentalDraft · pending medical review
Not yet medically reviewed — information on this site is in preparation and has not been verified by a medical reviewer.
Drug index / Concept / Serotonin syndrome
Concept

Serotonin syndrome

Serotonin syndrome (serotonin toxicity) is a potentially life-threatening reaction caused by too much serotonin activity in the brain, usually from combining two or more serotonergic drugs. It's the main reason certain drug combinations are dangerous — especially MDMA, stimulants, or psychedelics mixed with antidepressants (SSRIs, SNRIs) or MAOIs. It ranges from mild to rapidly fatal, and it's a medical emergency.

Overview

Serotonin syndrome, more precisely called serotonin toxicity, is a drug-induced condition caused by excessive serotonin activity in the nervous system. It classically presents as a triad: neuromuscular abnormalities (tremor, muscle rigidity, overactive reflexes, and clonus — rhythmic involuntary muscle contractions, the most telling sign), autonomic hyperactivity (fever, sweating, rapid heart rate, high blood pressure), and altered mental state (agitation, confusion, restlessness). It exists on a spectrum from mild and easily missed to a rapidly progressing, fatal emergency. There is no lab test that confirms it — diagnosis is clinical. Onset is usually fast, often within hours of the triggering dose or combination.

Source: peer-reviewed literature (NIH/PMC); Cleveland Clinic Journal of Medicine; Wikipedia (CC-BY-SA)

Risks & harms

Serotonin syndrome is the specific danger behind many 'do not combine' warnings in harm reduction. It most often occurs when two or more serotonin-raising substances are taken together, especially if they raise serotonin by different mechanisms — the highest-risk combination is a monoamine oxidase inhibitor (MAOI) with an SSRI, SNRI, or another serotonergic drug. Substances that commonly contribute include MDMA and MDA, other stimulants, tramadol, meperidine (pethidine), dextromethorphan (DXM), St. John's Wort, triptans, and antidepressants (SSRIs, SNRIs, MAOIs, tricyclics). A critical and under-recognized case is ayahuasca, which contains MAOIs — combining it with other serotonergic drugs (SSRIs, MDMA, other stimulants) can be acutely dangerous. It can also occur from a single serotonergic drug taken in overdose. Because some drugs (like fluoxetine, and irreversible MAOIs) stay active for weeks, a dangerous interaction can occur even weeks after stopping one drug. Warning signs to act on: agitation or confusion, heavy sweating and fever, shivering or muscle twitching/jerking, a racing heart, and muscle rigidity. Severe cases cause dangerously high body temperature, seizures, and organ failure. This is a medical emergency — if someone shows these signs after taking serotonergic drugs, call 911 immediately; Poison Control (1-800-222-1222) can advise. Do not wait for the full triad to appear. This page has not yet been medically reviewed.

Source: peer-reviewed literature (NIH/PMC); Cleveland Clinic Journal of Medicine; SAMHSA

Images

Visual references coming soon.

Forensic dossier

Draft · every field is source-cited or marked “Unknown — pending review”

Identity

PubChem CID
N/A — no single PubChem compound (mixture/class/plant/concept)
IUPAC name
N/A — no single PubChem compound (mixture/class/plant/concept)
Molecular formula
N/A — no single PubChem compound (mixture/class/plant/concept)
SMILES
N/A — no single PubChem compound (mixture/class/plant/concept)
InChIKey
N/A — no single PubChem compound (mixture/class/plant/concept)
Synonyms / aliases
serotonin toxicity

Composition

Composition
Unknown — pending review (no single compound; needs an epidemiology / composition source)

Physical / pill characteristics

Dosage form
Unknown — pending review (no Rx/OTC label; illicit — pill visuals = FIRST-PARTY submissions only, never generated or scraped)
Route
Unknown — pending review
Shape
Unknown — pending review
Color
Unknown — pending review
Imprint
Unknown — pending review
Score
Unknown — pending review

Scheduling & legal status

US schedule
Unknown — pending review
International
See EMCDDA/EUDA + WHO — synthesize per jurisdictionEMCDDA / EUDA · retrieved 2026-06-18

Effects

Effects
Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus · retrieved 2026-06-18

Risks

Risks
Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus · retrieved 2026-06-18

Interactions

Interactions
Unknown — pending review

Sources

← Back to the drug index